Bearish flow noted in BridgeBio Pharma with 1,661 puts trading, or 1.6x expected. Most active are May-24 20 puts and Nov-23 30 calls, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 1.73, while ATM IV is up nearly 2 points on the day. Earnings are expected on November 2nd.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BBIO:
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BridgeBio reports inducement grants under Nasdaq listing rule
- BridgeBio Pharma to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
- BridgeBio Pharma Announces Positive Feedback from the U.S. FDA and EU EMA on the Regulatory Path for a Pivotal Phase 3 Trial of Infigratinib in Children with Achondroplasia
- BridgeBio announces positive feedback from FDA on PROPEL3